These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 321823)

  • 21. [Pulmonary hyaline membranes in newborn infants. (Idiopathic respiratory distress syndrome)].
    Göcke H; Bienengräber A
    Zentralbl Chir; 1974 Aug; 99(34):1057-61. PubMed ID: 4613061
    [No Abstract]   [Full Text] [Related]  

  • 22. Substrate specificity of plasminogen activator in the lungs of rabbits and rodents. Ionic enhancement of plasminogen activator activity.
    Lieberman J
    Lab Invest; 1968 Nov; 19(5):466-72. PubMed ID: 4235267
    [No Abstract]   [Full Text] [Related]  

  • 23. Pulmonary plasminogen-activator activity in hyaline membrane disease. A reevaluation on human, bovine, and rabbit fibrin substrates.
    Lieberman J
    Pediatr Res; 1969 Jan; 3(1):11-8. PubMed ID: 5766408
    [No Abstract]   [Full Text] [Related]  

  • 24. Letter: Fibrinolytic activity in hyaline membrane disease.
    Lieberman J; Ekelund H
    Acta Paediatr Scand; 1973 Nov; 62(6):668-9. PubMed ID: 4800998
    [No Abstract]   [Full Text] [Related]  

  • 25. Fibrinolytic acivity in lung tissue from neonates with hyaline membrane disease.
    Ekelund H; Pandolfi M; Ostberg G; Bjernstad A
    Acta Paediatr Scand; 1973 Mar; 62(2):149-57. PubMed ID: 4570825
    [No Abstract]   [Full Text] [Related]  

  • 26. STUDIES ON HYALINE MEMBRANE DISEASE. II. THE ONTOGENY OF THE FIBRINOLYSIN SYSTEM.
    AMBRUS CM; WEINTRAUB DH; NISWANDER KR; AMBRUS JL
    Pediatrics; 1965 Jan; 35():91-6. PubMed ID: 14223231
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention of the respiratory distress syndrome of the newborn. Value of antepartum treatment with glucocorticoids].
    Fargier P; Salle B; Baud ; Gagnaire JC; Arnaud P; Magnin P
    Nouv Presse Med; 1974 Jun; 3(25):1595-1597. PubMed ID: 4602249
    [No Abstract]   [Full Text] [Related]  

  • 28. [Betamethasone in the prevention of pulmonary hyaline membrane disease: the results and applicability of G.C. Liggins' protocol].
    Scarcella A; De Filippis A; Cascioli CF; Balletta M; Rossi E; Ciccimarra F
    Minerva Pediatr; 1983 Apr; 35(7):307-11. PubMed ID: 6346034
    [No Abstract]   [Full Text] [Related]  

  • 29. [The role of steroid therapy in the prevention of respiratory distress syndrome in the newborn].
    Szabó I; Csaba I; Novák P; Drozgyik I
    Orv Hetil; 1977 Mar; 118(10):566-8. PubMed ID: 840473
    [No Abstract]   [Full Text] [Related]  

  • 30. [Surfactant and respiratory distress syndrome].
    Renovanz HD; von Seefeld H
    Prax Klin Pneumol; 1978 Jul; 32(7):443-66. PubMed ID: 28518
    [No Abstract]   [Full Text] [Related]  

  • 31. [Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study].
    Fekih M; Chaieb A; Sboui H; Denguezli W; Hidar S; Khairi H
    Tunis Med; 2002 May; 80(5):260-5. PubMed ID: 12534029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Critical study of the use of glucocorticoids in the prevention of hyaline membrane disease].
    Leroy JL
    J Gynecol Obstet Biol Reprod (Paris); 1982; 11(1):152-7. PubMed ID: 6896522
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of oxygen and constant positive pressure breathing on aADCO2 in hyaline membrane disease.
    Hansen TN; Corbet AJ; Kenny JD; Courtney JD; Rudolph AJ
    Pediatr Res; 1979 Oct; 13(10):1167-71. PubMed ID: 388333
    [No Abstract]   [Full Text] [Related]  

  • 34. Ontogeny of fibrinolysin system and its role in pathogenesis of hyaline membrane disease of infants.
    Ambrus CM
    Fed Proc; 1966; 25(1):68-72. PubMed ID: 5006574
    [No Abstract]   [Full Text] [Related]  

  • 35. Experimental hyaline membrane disease in the premature monkey: effects of antenatal dexamethasone.
    Kessler DL; Truog WE; Murphy JH; Palmer S; Standaert TA; Woodrum DE; Hodson WA
    Am Rev Respir Dis; 1982 Jul; 126(1):62-9. PubMed ID: 6920252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal prophylaxis of hyaline membrane disease with prednisolone: advantages and disadvantages.
    Wauer RR; Hengst P; Grauel EL
    Biol Res Pregnancy Perinatol; 1983; 4(3):113-9. PubMed ID: 6354282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced incidence of hyaline membrane disease in extremely premature infants following delay of delivery in mother with preterm labor: use of ritodrine and betamethasone.
    Kwong MS; Egan EA
    Pediatrics; 1986 Nov; 78(5):767-74. PubMed ID: 3532016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of fibrin in the formation of hyaline membranes].
    Rukosuev VS; Surkova NA
    Pediatriia; 1971 Oct; 50(10):58-61. PubMed ID: 4112285
    [No Abstract]   [Full Text] [Related]  

  • 39. [Disorders of hemostasis and respiratory distress in the newborn. Hyaline membrane disease and transient respiratory distress].
    Leroux B; Droulle-Bertignon C; Potron G; Ferrand O; Mesmin F
    Ann Pediatr (Paris); 1976 Feb; 23(2):89-96. PubMed ID: 16104234
    [No Abstract]   [Full Text] [Related]  

  • 40. Hyaline-membrane formation and pulmonary plasminogen-activator activity in various strains of mice.
    Lieberman J; Kellogg F
    Pediatrics; 1967 Jan; 39(1):75-81. PubMed ID: 5334048
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.